Raymond E. Cabillot Sells 836 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) Stock

Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot sold 836 shares of the business’s stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $50.00, for a total transaction of $41,800.00. Following the sale, the director now owns 278,109 shares in the company, valued at $13,905,450. This trade represents a 0.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Pro-Dex Price Performance

Shares of NASDAQ PDEX opened at $51.40 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.58 and a quick ratio of 1.44. The company has a market cap of $167.62 million, a price-to-earnings ratio of 25.57 and a beta of 0.68. The stock’s 50-day moving average is $40.45 and its two-hundred day moving average is $40.43. Pro-Dex, Inc. has a 1-year low of $16.84 and a 1-year high of $59.60.

Pro-Dex (NASDAQ:PDEX) last released its earnings results on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.23. Pro-Dex had a net margin of 11.06% and a return on equity of 21.68%. Analysts forecast that Pro-Dex, Inc. will post 2 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of Pro-Dex from a “buy” rating to a “hold” rating in a research note on Wednesday, March 12th.

Institutional Investors Weigh In On Pro-Dex

Institutional investors have recently modified their holdings of the company. FMR LLC grew its stake in shares of Pro-Dex by 34.9% during the third quarter. FMR LLC now owns 3,973 shares of the medical instruments supplier’s stock worth $119,000 after purchasing an additional 1,028 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in shares of Pro-Dex during the 4th quarter worth about $202,000. Trexquant Investment LP purchased a new position in shares of Pro-Dex in the 4th quarter valued at about $252,000. Integrated Quantitative Investments LLC acquired a new stake in shares of Pro-Dex during the 4th quarter worth about $254,000. Finally, Arrowstreet Capital Limited Partnership purchased a new stake in Pro-Dex during the fourth quarter worth approximately $255,000. 15.28% of the stock is owned by hedge funds and other institutional investors.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.